Connect with us

Métis Nation Saskatchewan Business Magazine | Sask Métis News | Métis Nation Entrepreneurs

Métis Nation Saskatchewan Business Magazine | Sask Métis News | Métis Nation Entrepreneurs

Risks of rare blood clot even lower with second dose of AstraZeneca, experts say


Entrepreneurs

Risks of rare blood clot even lower with second dose of AstraZeneca, experts say

The risk of developing rare blood clots is even lower when receiving a second dose of the AstraZeneca COVID-19 vaccine, with experts reiterating that the benefits outweigh the risk in Canada’s race to get inoculated.

Subscribe to the newsletter news

We hate SPAM and promise to keep your email address safe

Metis Studies

Online Entrepreneurs

Top Stories

To Top